Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Evaluation of Precision of thePlasmodium knowlesiGrowth Inhibition Assay forPlasmodium vivaxDuffy-Binding Protein-based Malaria Vaccine Development

Mertens JE. et al, (2024)

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial

Martinez FJ. et al, (2024), npj Vaccines, 9

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

King LDW. et al, (2024)

The PfRCR complex bridges malaria parasite and erythrocyte during invasion.

Farrell B. et al, (2023), Nature

Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein

Watson QD. et al, (2023), Malaria Journal, 22

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5

Wang LT. et al, (2023)

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

Barrett JR. et al, (2023)

Cellular iron governs the host response to malaria.

Wideman SK. et al, (2023), PLoS pathogens, 19

Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes.

Jamwal A. et al, (2023), eLife, 12

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.

Mitsi E. et al, (2023), Nature communications, 14

The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.

Weiss GE. et al, (2023), PLoS pathogens, 19

A systematic analysis of the human immune response to Plasmodium vivax

Bach FA. et al, (2023), Journal of Clinical Investigation

PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial

Martinez FJ. et al, (2023)

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.

Silk SE. et al, (2023), Med (New York, N.Y.)

Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.

Miura K. et al, (2023), Malaria journal, 22

Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

Silk SE. et al, (2023)

Analyses of vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

Barrett JR. et al, (2023)

Naturally-acquired and Vaccine-induced Human Monoclonal Antibodies to Plasmodium vivax Duffy Binding Protein Inhibit Invasion of Plasmodium knowlesi (PvDBPOR) Transgenic Parasites.

Watson QD. et al, (2023)

The Dual Action of Human Antibodies Specific toPlasmodium falciparumPfRH5 and PfCyRPA: Blocking Invasion and Inactivating Extracellular Merozoites

Weiss GE. et al, (2023)

Cellular iron governs the host response to malaria

Wideman SK. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?